Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica.
Chakroborty A, Pritchard DR, Bouillon ME, Cervi A, Kraehenbuehl R, Wild C, Fenn C, Holdsworth P, Capner C, Padalino G, Forde-Thomas JE, Payne J, Smith BG, Fisher M, Lahmann M, Baird MS, Hoffmann KF.
Chakroborty A, et al. Among authors: hoffmann kf.
Pharmaceutics. 2023 Jul 3;15(7):1869. doi: 10.3390/pharmaceutics15071869.
Pharmaceutics. 2023.
PMID: 37514055
Free PMC article.